Neuro-oncology
Reliable cognitive changes the first year following guideline-based treatment of IDH mutated gliomas: a longitudinal multicenter study.
Isabelle Rydén, Francesco Latini, Åsa Alberius Munkhammar, Per Hellström, Alice Neimantaite, Andrew Lycett, Dima Harba, Louise Carstam, Malin Blomstrand, Maria Zetterling, Anja Smits, Asgeir S Jakola
Published: 202510.1093/neuonc/noaf263
Abstract
BACKGROUND: Management of isocitrate dehydrogenase (IDH) mutated gliomas is multidisciplinary and current guidelines support early multimodal treatment. The effects of this treatment approach on cognition are less studied. We aimed to study changes i…
Preview only. Read the full abstract at the source